[{"Assets_0_Q1_USD":1291598000.0,"CommonStockSharesOutstanding_0_Q1_shares":54089087.0,"EarningsPerShareBasic_1_Q1_USD":0.39,"EarningsPerShareDiluted_1_Q1_USD":0.38,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":75698000.0,"NetIncomeLoss_1_Q1_USD":21187000.0,"StockholdersEquity_0_Q1_USD":335446000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":55123000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":54015000.0,"Ticker":"SYNH","CIK":"1610950","name":"INC RESEARCH HOLDINGS, INC.","OfficialName":"Syneos Health Inc. Class A Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"8107202548.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20170510"}]